Literature DB >> 22847631

A new link to mitochondrial impairment in tauopathies.

Kathrin L Schulz1, Anne Eckert, Virginie Rhein, Sören Mai, Winfried Haase, Andreas S Reichert, Marina Jendrach, Walter E Müller, Kristina Leuner.   

Abstract

Tauopathies like the "frontotemporal dementia with Parkinsonism linked to chromosome 17" (FTDP-17) are characterized by an aberrant accumulation of intracellular neurofibrillary tangles composed of hyperphosphorylated tau. For FTDP-17, a pathogenic tau mutation P301L was identified. Impaired mitochondrial function including disturbed dynamics such as fission and fusion are most likely major pathomechanisms of most neurodegenerative diseases. However, very little is known if tau itself affects mitochondrial function and dynamics. We addressed this question using SY5Y cells stably overexpressing wild-type (wt) and P301L mutant tau. P301L overexpression resulted in a substantial complex I deficit accompanied by decreased ATP levels and increased susceptibility to oxidative stress. This was paralleled by pronounced changes in mitochondrial morphology, decreased fusion and fission rates accompanied by reduced expression of several fission and fusion factors like OPA-1 or DRP-1. In contrast, overexpression of wt tau exhibits protective effects on mitochondrial function and dynamics including enhanced complex I activity. Our findings clearly link tau bidirectional to mitochondrial function and dynamics, identifying a novel aspect of the physiological role of tau and the pathomechanism of tauopathies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22847631     DOI: 10.1007/s12035-012-8308-3

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  60 in total

1.  Mitochondrial dynamics generate equal distribution but patchwork localization of respiratory Complex I.

Authors:  Karin B Busch; Juergen Bereiter-Hahn; Ilka Wittig; Hermann Schagger; Marina Jendrach
Journal:  Mol Membr Biol       Date:  2006 Nov-Dec       Impact factor: 2.857

Review 2.  Molecular machinery of mitochondrial fusion and fission.

Authors:  Benedikt Westermann
Journal:  J Biol Chem       Date:  2008-03-27       Impact factor: 5.157

3.  An ultrastructural analysis of the effects of accumulation of neurofibrillary tangle in pyramidal neurons of the cerebral cortex in Alzheimer's disease.

Authors:  P Q Sumpter; D M Mann; C A Davies; P O Yates; J S Snowden; D Neary
Journal:  Neuropathol Appl Neurobiol       Date:  1986 May-Jun       Impact factor: 8.090

4.  Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.

Authors:  Hélène C F Côté; Zabrina L Brumme; Kevin J P Craib; Christopher S Alexander; Brian Wynhoven; Lillian Ting; Hubert Wong; Marianne Harris; P Richard Harrigan; Michael V O'Shaughnessy; Julio S G Montaner
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

5.  The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.

Authors:  S P Crouch; R Kozlowski; K J Slater; J Fletcher
Journal:  J Immunol Methods       Date:  1993-03-15       Impact factor: 2.303

6.  Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis.

Authors:  Yang-ja Lee; Seon-Yong Jeong; Mariusz Karbowski; Carolyn L Smith; Richard J Youle
Journal:  Mol Biol Cell       Date:  2004-09-08       Impact factor: 4.138

7.  FTDP-17 mutations compromise the ability of tau to regulate microtubule dynamics in cells.

Authors:  Janis M Bunker; Kathy Kamath; Leslie Wilson; Mary Ann Jordan; Stuart C Feinstein
Journal:  J Biol Chem       Date:  2006-02-21       Impact factor: 5.157

Review 8.  Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.

Authors:  Velandai Srikanth; Annette Maczurek; Thanh Phan; Megan Steele; Bernadette Westcott; Damian Juskiw; Gerald Münch
Journal:  Neurobiol Aging       Date:  2009-05-22       Impact factor: 4.673

9.  Interaction of tau protein with the dynactin complex.

Authors:  Enrico Magnani; Juan Fan; Laura Gasparini; Matthew Golding; Meredith Williams; Giampietro Schiavo; Michel Goedert; Linda A Amos; Maria Grazia Spillantini
Journal:  EMBO J       Date:  2007-10-11       Impact factor: 11.598

10.  Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy.

Authors:  Véronique Schaeffer; Isabelle Lavenir; Sefika Ozcelik; Markus Tolnay; David T Winkler; Michel Goedert
Journal:  Brain       Date:  2012-06-10       Impact factor: 13.501

View more
  52 in total

Review 1.  Shedding light on mitophagy in neurons: what is the evidence for PINK1/Parkin mitophagy in vivo?

Authors:  Nadia Cummins; Jürgen Götz
Journal:  Cell Mol Life Sci       Date:  2017-10-30       Impact factor: 9.261

Review 2.  Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases.

Authors:  Zhi-Dong Zhou; Wuan-Ting Saw; Eng-King Tan
Journal:  Mol Neurobiol       Date:  2016-09-08       Impact factor: 5.590

Review 3.  Inhibitors of mitochondrial fission as a therapeutic strategy for diseases with oxidative stress and mitochondrial dysfunction.

Authors:  P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 4.  Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.

Authors:  Qian Cai; Prasad Tammineni
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Depletion of Mitofusin-2 Causes Mitochondrial Damage in Cisplatin-Induced Neuropathy.

Authors:  Ilja Bobylev; Abhijeet R Joshi; Mohammed Barham; Wolfram F Neiss; Helmar C Lehmann
Journal:  Mol Neurobiol       Date:  2017-01-21       Impact factor: 5.590

6.  Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity.

Authors:  Cliona Stack; Shari Jainuddin; Ceyhan Elipenahli; Meri Gerges; Natalia Starkova; Anatoly A Starkov; Mariona Jové; Manuel Portero-Otin; Nathalie Launay; Aurora Pujol; Navneet Ammal Kaidery; Bobby Thomas; Davide Tampellini; M Flint Beal; Magali Dumont
Journal:  Hum Mol Genet       Date:  2014-02-20       Impact factor: 6.150

Review 7.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

Review 8.  Connecting the dots between tau dysfunction and neurodegeneration.

Authors:  Bess Frost; Jürgen Götz; Mel B Feany
Journal:  Trends Cell Biol       Date:  2014-08-26       Impact factor: 20.808

Review 9.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

Review 10.  The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's Disease.

Authors:  Sanjib Guha; Gail V W Johnson; Keith Nehrke
Journal:  Mol Neurobiol       Date:  2020-08-26       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.